Vasoconstriction
Vasoconstriction(血管收缩)
Vasoconstriction 相关产品(59)
- GC45131Urotensin II (human) (trifluoroacetate salt)纯度: >95.00%
A neuropeptide agonist of the urotensin II receptor
- GC46362[Sar9, Met(O2)11]-Substance P (trifluoroacetate salt)纯度: >95.00%
A neuropeptide with diverse biological activities
- GC46856Angiotensin II (5-8) (human, rat, mouse) (trifluoroacetate salt)纯度: >95.00%
An endogenous angiotensin II fragment
- GC47292ent-8-iso Prostaglandin F2α-d9纯度: >99.00%
A neuropeptide with diverse biological activities
- GC47423HeptaminolCAS: 372-66-7纯度: >95.00%
An aliphatic amine with cardiotonic and sympathomimetic activities
- GC48117Sumatriptan-d6 (succinate)CAS: 1397195-80-0纯度: >99.00%
An internal standard for the quantification of sumatriptan
- GC48243Vardenafil-d5CAS: 1189685-70-8纯度: >99.00%
An internal standard for the quantification of vardenafil
- GC48508(4-Carboxybutyl-d4)triphenylphosphonium (bromide)CAS: 42932-63-8纯度: >99.00%
An internal standard for the quantification of (4-carboxybutyl)triphenylphosphonium
- GC48583Rizatriptan-d6 (benzoate salt)CAS: 1216984-85-8纯度: >99.00%
An internal standard for the quantification of rizatriptan
- GC48997Argipressin (acetate)CAS: 129979-57-3纯度: >95.00%
A peptide hormone with vasoconstrictive and antidiuretic activities
- GC49138Naphazoline-d4 (hydrochloride)纯度: >99.00%
An internal standard for the quantification of naphazoline
- GC49413Rizatriptan N-oxideCAS: 260435-42-5纯度: >90.00%
A potential impurity found in commercial preparations of rizatriptan
- GC49467β-Aescin (97-103%(T),beta≥60%(HPLC)(Lossondrying≤5%))CAS: 11072-93-8纯度: 不显示
A triterpenoid saponin with diverse biological activities
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC45131 | Urotensin II (human) (trifluoroacetate salt) | - | >95.00% | |
A neuropeptide agonist of the urotensin II receptor | ||||
| GC45198 | α-CGRP (8-37) (human) (trifluoroacetate salt) | - | >95.00% | |
An antagonist of CGRP receptors | ||||
| GC46362 | [Sar9, Met(O2)11]-Substance P (trifluoroacetate salt) | - | >95.00% | |
A neuropeptide with diverse biological activities | ||||
| GC46525 | 20-HETE-d6 | 2548939-89-3 | >99.00% | |
An internal standard for the quantification of 20-HETE | ||||
| GC46856 | Angiotensin II (5-8) (human, rat, mouse) (trifluoroacetate salt) | - | >95.00% | |
An endogenous angiotensin II fragment | ||||
| GC47292 | ent-8-iso Prostaglandin F2α-d9 | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC47423 | Heptaminol | 372-66-7 | >95.00% | |
An aliphatic amine with cardiotonic and sympathomimetic activities | ||||
| GC47479 | JP-1302 (hydrochloride hydrate) | - | >98.00% | |
An α 2C -adrenergic receptor antagonist | ||||
| GC47768 | Neuromedin U-25 (human) (trifluoroacetate salt) | - | >95.00% | |
A neuropeptide with diverse roles | ||||
| GC48001 | Prostaglandin F2α-d9 | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC48117 | Sumatriptan-d6 (succinate) | 1397195-80-0 | >99.00% | |
An internal standard for the quantification of sumatriptan | ||||
| GC48229 | Urotensin II (goby) (trifluoroacetate salt) | - | >95.00% | |
A peptide vasoconstrictor | ||||
| GC48243 | Vardenafil-d5 | 1189685-70-8 | >99.00% | |
An internal standard for the quantification of vardenafil | ||||
| GC48508 | (4-Carboxybutyl-d4)triphenylphosphonium (bromide) | 42932-63-8 | >99.00% | |
An internal standard for the quantification of (4-carboxybutyl)triphenylphosphonium | ||||
| GC48583 | Rizatriptan-d6 (benzoate salt) | 1216984-85-8 | >99.00% | |
An internal standard for the quantification of rizatriptan | ||||
| GC48916 | Etilefrine (hydrochloride) | 943-17-9 | >98.00% | |
A sympathomimetic amine | ||||
| GC48997 | Argipressin (acetate) | 129979-57-3 | >95.00% | |
A peptide hormone with vasoconstrictive and antidiuretic activities | ||||
| GC49138 | Naphazoline-d4 (hydrochloride) | - | >99.00% | |
An internal standard for the quantification of naphazoline | ||||
| GC49413 | Rizatriptan N-oxide | 260435-42-5 | >90.00% | |
A potential impurity found in commercial preparations of rizatriptan | ||||
| GC49467 | β-Aescin (97-103%(T),beta≥60%(HPLC)(Lossondrying≤5%)) | 11072-93-8 | 不显示 | |
A triterpenoid saponin with diverse biological activities | ||||
| GC49493 | IRL 1620 (trifluoroacetate salt) | - | >98.00% | |
A peptide ET B receptor agonist | ||||
| GC49634 | Isoflupredone | 338-95-4 | >95.00% | |
A glucocorticoid and mineralocorticoid receptor agonist | ||||
| GC49885 | BQ-3020 (trifluoroacetate salt) | - | >90.00% | |
A peptide ET B receptor antagonist | ||||
| GC52005 | Triazolomethylindole-3-acetic Acid | 177270-91-6 | >95.00% | |
A metabolite of rizatriptan | ||||